作者
Behnoosh Tahbazlahafi, Malihe Paknejad, Shahnaz Khaghani, Sahar Sadegh-Nejadi, Ehsan Khalili
发表日期
2021/7/1
期刊
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)
卷号
21
期号
7
页码范围
1312-1318
出版商
Bentham Science Publishers
简介
Background
Osteosarcoma (OS) is the basic bone neoplasm with lower survival and poor prognosis. It is distinguished by its offensive nature and metastatic potential. The fundamental death source in OS patients is lung metastasis. In addition, the proliferation and cell migration are thus essential for cancer progression, especially for intrusion and transformation. Several studies have illustrated that 1,25-Dihydroxyvitamin D (1,25(OH)2D) has a critical role in the growth and differentiation of bone. However, knowledge of the outcome of 1,25(OH)2D on the progression and incursion of osteosarcoma cells is minimal.
Objective
The present study aimed to analyze the effect of different concentrations of 1,25(OH)2D on the multiplication, progression, and intrusion of OS cells and verify the effective doses of 1,25(OH)2D that can decrease the intensity of the disease and improving the prognosis in OS patients.
Methods …
引用总数
学术搜索中的文章
B Tahbazlahafi, M Paknejad, S Khaghani… - Endocrine, Metabolic & Immune Disorders-Drug …, 2021